Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Biotech
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Sanofi is handing back a phase 2-stage natural killer cell engager and canceling another cancer trial.
James Waldron
Apr 23, 2025 6:35am
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
Apr 17, 2025 8:51am
Third Rock-backed Merida unveils with $121M for autoimmune plans
Apr 8, 2025 11:03am
Patient suffers side effect in Cabaletta CAR-T trial
Apr 2, 2025 6:55am
Nkarta lays off 3rd of staff to fund autoimmune CAR NK program
Mar 27, 2025 6:40am
Abcuro takes $200M series C to fund KLRG1 antibody pivotal trial
Feb 12, 2025 8:30am
